Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: Dis Colon Rectum. 2016 Jul;59(7):601–606. doi: 10.1097/DCR.0000000000000606

Table 1.

Representative comments from ASCRS membership

Supportive
“Agree with reassessment of tumor response immediately preop…”
“Great job.”
“Ideally should be best practice, but might not be achievable. May be more useful as minimum acceptable.”
“To maintain or ensure standards, probably needs some sort of reporting to be sure it gets done.”
Too Restrictive
“I don’t think we need to advocate for repeating any radiographic imaging after neoadjuvant treatment, do we?”
“Referral to medical oncologist [for specific stages]?”
“Don’t need postop checklist.”
“Pouch vs. no pouch sounds mandatory.”
“Would seem colorectal specialists don’t need a checklist.”
“Tumor board not always applicable – hurts high-volume practice.”
Too Vague
“”Need relation of tumor to [rectal] valves and anterior/posterior.”
“Consider assessment of post-op sexual function, quality of life, bowel function, & stoma management.”
“Request standardization of pathology reporting”
“Need pathologist’s synoptic report.”
“Add [intraoperative assessment] for ureter.”
“Add family history to pre-op evaluation.”